Overview
Pitavastatin on Carotid Intima-media Thickness
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study is aimed to analyze the effects of aggressive and conventional lipid lowering therapy with Pravastatin on carotid intima-media thickness (IMT) in patients with hyperlipidemia and abnormal thickening of IMT.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Kyoto Prefectural University of MedicineTreatments:
PitavastatinCriteria
Inclusion Criteria:- Diagnosed as having hyperlipidemia
- LDL-C at the time of enrollment is no less than 100
- Common carotid IMT is 1.1 mm and over
Exclusion Criteria:
- Received or planned to receive intervention on carotid arteries during the study
period
- Overt liver dysfunction (ALT; 100 IU/L and over)
- Overt renal dysfunction (serum creatinine; 2.0 mg/dL and over)
- Receiving Cyclosporin
- Hyperreactive to Pitavastatin
- During pregnancy or lactation